19 June 2023 : Clinical Research
B-Type Natriuretic Peptide Can Distinguish Ischemic Stroke Subtypes Better than Other Cardiac Biomarkers
Ping Liang12ABCEF, Shuang Han12ADG, Yucen Jiang12B, Huikai Miao3BD*, Xiaowei Qi12ADGDOI: 10.12659/MSM.939829
Med Sci Monit 2023; 29:e939829
Table 1 Baseline characteristics of the study population.
| Groups | Number (percentage)/median (inter-quartile range) | P | |||
|---|---|---|---|---|---|
| SVO | LAA | CE | Control | ||
| N | 67 | 104 | 52 | 75 | |
| Age | 67.6±11.2 | 69.0±10.2 | 71.4±11.0 | 67.4±7.1 | 0.120 |
| Male (%) | 37 (55.2%) | 69 (66.3%) | 34 (65.4%) | 45 (60%) | 0.472 |
| BMI (kg/m) | 23.5±2.2 | 23.1±1.5 | 23.4±1.7 | 23.0±1.5 | 0.175 |
| Emergency treatment (%) | 8 (11.9%) | 36 (34.6%) | 48 (92.3%) | – | <0.001 |
| Heart rate | 80 (70–90) | 75 (67.25–83) | 78 (68–92) | 76 (72–80) | 0.251 |
| SBP | 135 (125–151) | 144 (134–158) | 149.5 (143–164.5) | 130 (121–140) | <0.001 |
| DBP | 81 (75–91) | 84 (77–91) | 89 (77–100) | 80 (75–88) | 0.005 |
| History of hypertension | 43 (64.2%) | 75 (72.1%) | 39 (75%) | 30 (40%) | <0.001 |
| History of diabetes | 17 (25.4%) | 39 (37.5%) | 16 (30.8%) | 11 (14.7%) | 0.008 |
| History of CHD | 4 (6%) | 12 (11.5%) | 8 (15.4%) | 4 (5.3%) | 0.163 |
| History of stroke | 15 (22.4%) | 37 (35.6%) | 15 (30.6%) | 0 (0%) | <0.001 |
| History of atrial fibrillation | 1 (1.5%) | 4 (3.8%) | 21 (40.4%) | 0 (0%) | <0.001 |
| NIHSS score | 2 (2–3) | 3 (2–4) | 12 (8–17) | – | <0.001 |
| BMI – body mass index; SBP – systolic blood pressure; DBP – diastolic blood pressure; LAA – large-artery atherosclerosis; CE – cardioembolism; SVO – small-vessel occlusion; CHD – coronary heart disease; NIHSS – The National Institutes of Health Stroke Scale. | |||||